Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 5,965-5,976 of 10,612

Drug study icon

TerminatedNCT01917318

Iloperidone for Symptoms of Arousal in PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 89 Years

Countries: United States
Sponsor: University of Colorado, Denver
Condition: PTSD

Drug study icon

CompletedNCT02413918

Iloperidone in Mixed States of Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States
Sponsor: The University of Texas Health Science Center at San Antonio
Condition: Bipolarity

Drug study icon

SuspendedNCT04640636

IM Ketamine vs Midazolam for Suicidal ER Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Suicidality, Depression, ...DrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Suicidality, Depression, ...

Device study icon

CompletedNCT02853032

Image-guided, Robotically Delivered Transcranial Magnetic Stimulation Treatment for Combat-Related PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDeviceFrom 18 Years to 65 Years

Countries: United States
Sponsor: The University of Texas Health Science Center at San Antonio
Condition: PTSD

Behavioral study icon

TerminatedNCT00837382

Imagery Rescripting for Posttraumatic Nightmares in Rural Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) Veterans With PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 18 Years to 64 Years

Countries: United States
Sponsor: US Department of Veterans Affairs
Condition: PTSD

Behavioral study icon

TerminatedNCT00875342

Imaginal Exposure & D-Cycloserine (DCS) for PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 18 Years to 70 Years

Countries: United States
Sponsor: Weill Medical College of Cornell University
Condition: PTSD

Behavioral study icon

CompletedNCT03934697

Imaginal Exposure II Study: In-Vivo

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersBehavioralOver 18 Years

Countries: United States
Sponsor: University of Louisville
Condition: Eating disorders

Behavioral study icon

Active Not RecruitingNCT06746337

IMAGINE: study of a Digital Group Intervention to Prevent Perinatal Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralOver 16 Years

Countries: United States
Sponsor: University of Washington
Condition: Depression

Other study type icon

TerminatedNCT03427424

Imaging Biomarker for Addiction Treatment Outcome

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionObservationalFrom 21 Years to 65 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Addiction

Other study type icon

TerminatedNCT01063335

Imaging Cannabinoid CB1 Receptors in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaObservationalFrom 18 Years to 55 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Schizophrenia

Drug study icon

WithdrawnNCT03999190

Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 35 Years

Countries: United States
Sponsor: NYU Langone Health
Condition: Schizophrenia

Drug study icon

CompletedNCT02348385

Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.